CCM
AERI

Convector Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Convector Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.45M Sell
38,444
-16,756
-30% -$370K 2.66% 18
2016
Q2 		$972K Sell
55,200
-4,800
-8% -$77.7K 1.34% 23
2016
Q1 		$730K Sell
60,000
-17,000
-22% -$269K 0.74% 31
2015
Q4 		$1.88M Buy
+77,000
New +$1.8M 1.77% 20

Other funds holding AERI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Convector Capital Management's AERI Position: Q3 2016 in Review

Convector Capital Management reduced its Aerie Pharmaceuticals (AERI) stake by 30% in Q3 2016, selling an estimated $370K and leaving 38,444 shares worth $1.45M. The position accounts for 2.66% of the portfolio, ranked #18.

Convector Capital Management first reported a position in AERI in Q4 2015 and has held it in 4 quarters since. The position peaked at $1.88M in Q4 2015. 162 funds tracked by Wall St. Rank hold AERI as of Q3 2016.

  • Convector Capital Management held 38,444 shares of Aerie Pharmaceuticals worth $1.45M as of Q3 2016.
  • Convector Capital Management sold 16,756 Aerie Pharmaceuticals shares in Q3 2016, an estimated $370K.
  • Aerie Pharmaceuticals made up 2.66% of Convector Capital Management's portfolio in Q3 2016, its #18 holding.
  • Convector Capital Management first reported a position in Aerie Pharmaceuticals in Q4 2015 and has held it in 4 quarters since.
  • Convector Capital Management's Aerie Pharmaceuticals position peaked at $1.88M in Q4 2015.
  • 162 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2016.

Based on Convector Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.